- socially bharat
- September 17, 2024
BioStock: Medivir – live from ESMO in Barcelona
At the ESMO conference in Barcelona, Medivir presented mature results from its ongoing Phase Ib/IIa trial of fostrox in combination with
- socially bharat
- September 12, 2024
Medivir to present mature clinical data for fostrox + Lenvima at ESMO Conference and to host a webcast on September 16
Stockholm — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of